N-(3-Chloro-2-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine (Dacomitinib Impurity), 97%, 50mg

3,4-Bis(2-methoxyethoxy)benzaldehyde, 95.0%, 25g

4-(((tert-Butoxycarbonyl)amino)methyl)-3-chlorobenzoic acid, 95%, 1g

(1S,2R)-2-Phenylcyclopropanamine, 95.0%, 100mg

3-Bromo-N-ethylaniline, 95+%, 1g

ethyl 1-[(4-methoxyphenyl)methyl]-4-oxo-1H,4H,7H-pyrazolo[3,4-b]pyridine-5-carboxylate, 98%, 100mg

2,5-Dioxopyrrolidin-1-yl 6-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)hexanoate, 95+%, 1g

Bromoethane, min 99.5%, for synthesis, 250 ml, glass packaging

Methyl 3-amino-6-methylpyrazine-2-carboxylate, 95.0%, 10g

tert-Butyl 4-(4-bromobenzamido)piperidine-1-carboxylate, 95.0%, 1g

2-(2-Ethoxyethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 250mg

2-Bromo-4-fluorothiophenol, 97.0%, 5g

Methyl 4-chloro-3-(difluoromethoxy)benzoate, 98%, 250mg